Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1581 (Rev 09/2005) |
OMB No. 0651-0054 (Exp 12/31/2020) |
Request for Extension of Time to File a Statement of Use
(15 U.S.C. Section 1051(d))
The table below presents the data as entered.
Input Field
|
Entered
|
SERIAL NUMBER |
87686582 |
LAW OFFICE ASSIGNED |
LAW OFFICE 101 |
MARK SECTION |
MARK |
SYNTHEA (see, http://uspto.report/TM/87686582/mark.png) |
STANDARD CHARACTERS |
YES |
USPTO-GENERATED IMAGE |
YES |
LITERAL ELEMENT |
SYNTHEA |
OWNER SECTION (current) |
NAME |
The MITRE Corporation |
MAILING ADDRESS |
7515 Colshire Drive |
CITY |
McLean |
STATE |
Virginia |
ZIP/POSTAL CODE |
22102-7508 |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY |
United States |
PHONE |
202-371-2600 |
FAX |
202-371-2540 |
OWNER SECTION (proposed) |
NAME |
The MITRE Corporation |
MAILING ADDRESS |
7515 Colshire Drive |
CITY |
McLean |
STATE |
Virginia |
ZIP/POSTAL CODE |
22102-7508 |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY |
United States |
PHONE |
202-371-2600 |
FAX |
202-371-2540 |
EMAIL |
XXXX |
CORRESPONDENCE INFORMATION (current) |
NAME |
TRACY-GENE G. DURKIN |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE |
tm@sternekessler.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) |
tdurkin@sternekessler.com; jshirk@sternekessler.com |
CORRESPONDENCE INFORMATION (proposed) |
NAME |
Tracy-Gene G. Durkin |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE |
tm@sternekessler.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) |
tdurkin@sternekessler.com; jshirk@sternekessler.com; tfrancis@sternekessler.com |
DOCKET/REFERENCE NUMBER |
2272.2290000 |
GOODS AND/OR SERVICES SECTION |
INTERNATIONAL CLASS |
009 |
CURRENT IDENTIFICATION |
software program for generating synthetic patients and synthetic electronic patient healthcare records for use by the healthcare industry, for
research and innovation purposes, and for educational purposes; software that simulates the lifespan of synthetic patients for use by the healthcare industry, for research and innovation purposes,
and for educational purposes; software for modeling primary healthcare encounters, chronic conditions, and treatment protocols within a synthetic patient population for use by the healthcare
industry, for research and innovation purposes, and for educational purposes; software for generating synthetic patients for modeling the effects of health policy on patient access, patient health
outcomes, and health costs; software for simulating patients for modelling the effects of health policy on patient access, patient health outcomes, and health costs; software for simulating patients
with models of disease progression and corresponding standards of care to produce risk-free, realistic, synthetic, healthcare records at scale; computer software programs in the nature of a synthetic
patient population simulator used to generate synthetic patients and synthetic patient data; providing synthetic patient data and associated healthcare records for research, innovation, and
educational purposes; software for generating synthetic patient data for research, innovation, and educational purposes; software for generating synthetic patient healthcare records for research,
innovation, and educational purposes |
GOODS OR SERVICES |
KEEP ALL LISTED |
INTERNATIONAL CLASS |
042 |
CURRENT IDENTIFICATION |
Compiling data on synthetic patients and associated health records for research purposes in the field of medical science and medical
consultancy |
GOODS OR SERVICES |
KEEP ALL LISTED |
EXTENSION SECTION |
EXTENSION NUMBER |
3 |
ONGOING EFFORT |
product or service research or development |
ALLOWANCE MAIL DATE |
10/30/2018 |
STATEMENT OF USE |
YES |
PAYMENT SECTION |
NUMBER OF CLASSES |
2 |
SUBTOTAL AMOUNT [EXTENSION FEE] |
250 |
TOTAL AMOUNT |
250 |
SIGNATURE SECTION |
SIGNATURE |
/Tracy Durkin/ |
SIGNATORY'S NAME |
Tracy-Gene G. Durkin |
SIGNATORY'S POSITION |
Attorney of Record, Washington, DC Bar Member |
DATE SIGNED |
04/28/2020 |
SIGNATORY'S PHONE NUMBER |
202-371-2600 |
FILING INFORMATION |
SUBMIT DATE |
Tue Apr 28 15:24:20 ET 2020 |
TEAS STAMP |
USPTO/ESU-XX.XXX.XXX.XXX-
20200428152420509238-8768
6582-710f7e94338ee3fb9a89
57389f081d9185c7ca81d3ca8
b1beeb5148b114add056ae-CC
-24186744-202004281234068
53019 |
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1581 (Rev 09/2005) |
OMB No. 0651-0054 (Exp 12/31/2020) |
SOU Extension Request
(15 U.S.C. Section 1051(d))
To the Commissioner for Trademarks:
MARK: SYNTHEA (see, http://uspto.report/TM/87686582/mark.png)
SERIAL NUMBER: 87686582
OWNER AND/OR ENTITY INFORMATION
The owner proposes to amend the following:
Current: The MITRE Corporation, having an address of
7515 Colshire Drive
McLean, Virginia 22102-7508
United States
Phone: 202-371-2600
Fax: 202-371-2540
Proposed: The MITRE Corporation, having an address of
7515 Colshire Drive
McLean, Virginia 22102-7508
United States
Phone: 202-371-2600
Fax: 202-371-2540
Email: XXXX
The owner requests a six-month extension of time to file the Statement of Use under 37 C.F.R. Section 2.89 in this application. The Notice of Allowance mailing date was 10/30/2018.
For International Class 009:
Current identification: software program for generating synthetic patients and synthetic electronic patient healthcare records for use by the healthcare industry, for research and innovation
purposes, and for educational purposes; software that simulates the lifespan of synthetic patients for use by the healthcare industry, for research and innovation purposes, and for educational
purposes; software for modeling primary healthcare encounters, chronic conditions, and treatment protocols within a synthetic patient population for use by the healthcare industry, for research and
innovation purposes, and for educational purposes; software for generating synthetic patients for modeling the effects of health policy on patient access, patient health outcomes, and health costs;
software for simulating patients for modelling the effects of health policy on patient access, patient health outcomes, and health costs; software for simulating patients with models of disease
progression and corresponding standards of care to produce risk-free, realistic, synthetic, healthcare records at scale; computer software programs in the nature of a synthetic patient population
simulator used to generate synthetic patients and synthetic patient data; providing synthetic patient data and associated healthcare records for research, innovation, and educational purposes;
software for generating synthetic patient data for research, innovation, and educational purposes; software for generating synthetic patient healthcare records for research, innovation, and
educational purposes
For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice
of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate
control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this
specific class.
For International Class 042:
Current identification: Compiling data on synthetic patients and associated health records for research purposes in the field of medical science and medical consultancy
For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice
of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate
control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this
specific class.
This is the third extension request. The applicant has made the following ongoing efforts to use the mark in commerce on or in connection with each of those goods/services covered by the extension
request: product or service research or development
A Statement of Use has already been submitted or is being submitted along with the Extension request as evidence that applicant believes that it has made valid use of the mark in commerce. If
the USPTO finds the Statement of Use to be fatally defective, the applicant requests additional time to file an amended or substitute Statement of Use.
Correspondence Information (current):
TRACY-GENE G. DURKIN
PRIMARY EMAIL FOR CORRESPONDENCE: tm@sternekessler.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): tdurkin@sternekessler.com; jshirk@sternekessler.com
Correspondence Information (proposed):
Tracy-Gene G. Durkin
PRIMARY EMAIL FOR CORRESPONDENCE: tm@sternekessler.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): tdurkin@sternekessler.com; jshirk@sternekessler.com; tfrancis@sternekessler.com
Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the owner/holder and the owner's/holder's attorney, if appointed, and that all
official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $250 will be submitted with the form, representing payment for 2 classes.
Declaration
STATEMENTS: The signatory believes that: the applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all the goods/services under Section
1(b) in the notice of allowance or as subsequently modified, or, if applicable, the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the
mark in commerce on or in connection with all the goods/services/collective membership organization under Section 1(b) in the notice of allowance or as subsequently modified; and that to the best of
the signatory's knowledge and belief, no other persons, except, if applicable, members and concurrent users, have the right to use the mark in commerce, either in the identical form or in such near
resemblance as to be likely, when used on or in connection with the goods/services/collective membership organization of such other persons, to cause confusion or mistake, or to deceive.
DECLARATION: The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. §1001, and that such willful false statements and
the like may jeopardize the validity of the application or submission or any resulting registration, declares that all statements made of his/her own knowledge are true and that all statements made
on information and belief are believed to be true.
Signature: /Tracy Durkin/ Date Signed: 04/28/2020
Signatory's Name: Tracy-Gene G. Durkin
Signatory's Position: Attorney of Record, Washington, DC Bar Member
Signatory's Phone: 202-371-2600
RAM Sale Number: 87686582
RAM Accounting Date: 04/28/2020
Serial Number: 87686582
Internet Transmission Date: Tue Apr 28 15:24:20 ET 2020
TEAS Stamp: USPTO/ESU-XX.XXX.XXX.XXX-202004281524205
09238-87686582-710f7e94338ee3fb9a8957389
f081d9185c7ca81d3ca8b1beeb5148b114add056
ae-CC-24186744-20200428123406853019